QOLP-13. COMPARISON OF SYMPTOM BURDEN AND ASSOCIATED IMPACT ON DAILY LIFE IN GLIOBLASTOMA PATIENTS TREATED WITH AND WITHOUT TUMOR TREATING FIELDS

INTRODUCTION: Clinical trials have demonstrated that the use of low intensity alternating electric fields, known as Tumor Treating Fields (TTFields), via the Optune™ device extends overall survival times in patients with glioblastoma when combined with standard chemotherapy. In addition to survival...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Tipps, Megan, Tierney, Meghan, Monson, Caitlin, Jackson, Kelsey, Banerji, Nilanjana, Bruns, Patricia, Trusheim, John
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Quality of Life and Palliative Care
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650888/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.738
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares